Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The balance between B55α and Greatwall expression levels predicts sensitivity to Greatwall inhibition in cancer cells. | Nat Commun | 2025 | 40866357 | PubTator, text mining | PubMed |
| On the tumor cell growth limiting potential of newly synthesized acridine-1,8-dione derivatives. | Bioorg Chem | 2025 | 40865235 | PubTator, text mining | PubMed |
| Cardiotoxicity in Breast Cancer Therapy: Risks, Mechanisms, and Prevention Strategies. | Med Sci (Basel) | 2025 | 40843752 | PubTator, text mining | PubMed |
| Novel β-carboline derivatives show promise as dual-target inhibitors of DNA and TOP2A for the treatment of triple negative breast cancer. | Eur J Med Chem | 2025 | 40779814 | PubTator, text mining | PubMed |
| Unraveling the Role of Topoisomerase 3β (TOP3B) in mRNA Translation and Human Disease. | Wiley Interdiscip Rev RNA | 2025 | 40754336 | PubTator, text mining | PubMed |
| Hurdles of Sperm Success: Exploring the Role of DNases. | Int J Mol Sci | 2025 | 40725036 | PubTator, text mining | PubMed |
| Infantile epileptic spasms syndrome as a new phenotype in TOP2B deficiency caused by a de novo variant: a case report and literature review. | Front Pediatr | 2025 | 40656194 | PubTator, text mining | PubMed |
| Using pseudotime derivative on single-cell RNA sequencing data to identify genes undergoing cell cycle regulation. | Bioinform Adv | 2025 | 40655197 | PubTator, text mining | PubMed |
| Programmed DNA breaks drive chromatin reconfiguration and facilitate transcriptional potentiation at neuronal early response genes. | bioRxiv | 2025 | 40654939 | PubTator, text mining | PubMed |
| Mitochondrial topoisomerases, nucleoid architecture and mtDNA repair in human disease. | J Cell Sci | 2025 | 40621827 | PubTator, text mining | PubMed |
| Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review. | Drug Des Devel Ther | 2025 | 40620466 | PubTator, text mining | PubMed |
| Nonredundant roles of topoisomerase 2α and 2β in the cytosolic replication of vaccinia virus. | Nucleic Acids Res | 2025 | 40557872 | PubTator, text mining | PubMed |
| A salophen-type macrocyclic Schiff base ligand and its metal complexes: exploring in vitro anticancer efficacy via in silico topoisomerase IIβ enzyme targeting. | Dalton Trans | 2025 | 40512013 | PubTator, text mining | PubMed |
| Deciphering linezolid-induced hematologic toxicity: Targeting TOP2A and TOP2B via its primary metabolite PNU142586. | Sci Adv | 2025 | 40435237 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Lactylation-related Biomarkers and Potential Pathogenesis Mechanisms in Age-related Macular Degeneration. | Curr Genomics | 2025 | 40433417 | PubTator, text mining | PubMed |
| Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotection. | Nat Commun | 2025 | 40425539 | PubTator, text mining | PubMed |
| Recombinant Topoisomerase 2 Production Using Cultured Human Cell Lines. | Methods Mol Biol | 2025 | 40372648 | PubTator, text mining | PubMed |
| Mutagenesis of Intrinsically Disordered Domain Impacts Topoisomerase IIα Catalytic Activity. | Int J Mol Sci | 2025 | 40332112 | PubTator, text mining | PubMed |
| Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b. | Cardiooncology | 2025 | 40317097 | PubTator, text mining | PubMed |
| Extrachromosomal DNA replication and maintenance couple with DNA damage pathway in tumors. | Cell | 2025 | 40300601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=4